Arpin Regulates Migration Persistence by Interacting with Both Tankyrases and the Arp2/3 Complex.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
16 Apr 2021
Historique:
received: 17 03 2021
revised: 11 04 2021
accepted: 13 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 13 5 2021
Statut: epublish

Résumé

During cell migration, protrusion of the leading edge is driven by the polymerization of Arp2/3-dependent branched actin networks. Migration persistence is negatively regulated by the Arp2/3 inhibitory protein Arpin. To better understand Arpin regulation in the cell, we looked for its interacting partners and identified both Tankyrase 1 and 2 (TNKS) using a yeast two-hybrid screening and coimmunoprecipitation with full-length Arpin as bait. Arpin interacts with ankyrin repeats of TNKS through a C-terminal-binding site on its acidic tail, which overlaps with the Arp2/3-binding site. Arpin was found to dissolve the liquid-liquid phase separation of TNKS upon overexpression. To uncouple the interactions of Arpin with TNKS and Arp2/3, we introduced point mutations in the Arpin tail and attempted to rescue the increased migration persistence of the Arpin knockout cells using random plasmid integration or compensating knock-ins at the

Identifiants

pubmed: 33923443
pii: ijms22084115
doi: 10.3390/ijms22084115
pmc: PMC8073056
pii:
doi:

Substances chimiques

Carrier Proteins 0
arpin protein, human 0
TNKS2 protein, human EC 2.4.2.30
Tankyrases EC 2.4.2.30
TNKS protein, human EC 2.4.4.30

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Agence Nationale de la Recherche
ID : ANR-15-CE13-0016-01
Organisme : Institut National Du Cancer
ID : INCA_6521

Références

Structure. 2016 Sep 6;24(9):1573-81
pubmed: 27499439
Mol Cell Biol. 2012 Aug;32(15):3044-53
pubmed: 22645305
J Cancer. 2020 Jan 1;11(2):432-440
pubmed: 31897238
Cell. 2019 Jan 24;176(3):419-434
pubmed: 30682370
Cell. 2011 Jun 24;145(7):1012-22
pubmed: 21703446
Anticancer Res. 2018 Mar;38(3):1303-1310
pubmed: 29491053
Cell. 2011 Dec 9;147(6):1340-54
pubmed: 22153077
Cell Death Dis. 2016 Jul 21;7:e2302
pubmed: 27441654
Nat Commun. 2017 Dec 20;8(1):2214
pubmed: 29263426
Eur J Surg Oncol. 2019 May;45(5):769-775
pubmed: 30416079
Nat Cell Biol. 2005 Nov;7(11):1133-9
pubmed: 16244666
Nat Rev Mol Cell Biol. 2014 Sep;15(9):577-90
pubmed: 25145849
Nature. 2012 Mar 07;483(7389):336-40
pubmed: 22398450
J Cell Mol Med. 2016 Mar;20(3):450-8
pubmed: 26648569
J Biol Chem. 2003 Feb 14;278(7):5195-204
pubmed: 12475993
Nat Cell Biol. 2011 May;13(5):623-9
pubmed: 21478859
Biomed Res Int. 2019 Feb 20;2019:2686340
pubmed: 30915350
Physiol Rev. 2018 Jan 1;98(1):215-238
pubmed: 29212790
Mol Cell. 2016 Aug 4;63(3):498-513
pubmed: 27494558
FEBS Lett. 2012 Mar 23;586(6):897-904
pubmed: 22449978
Oncol Lett. 2018 Jun;15(6):8973-8982
pubmed: 29805633
Nature. 2009 Oct 1;461(7264):614-20
pubmed: 19759537
Nat Protoc. 2014 Aug;9(8):1931-43
pubmed: 25033209
BMC Biol. 2016 Jan 19;14:5
pubmed: 26787475
Cell Res. 2019 Jun;29(6):432-445
pubmed: 30971746
Int J Oncol. 2014 Jul;45(1):121-8
pubmed: 24789807
Chem Sci. 2020 Dec 17;12(3):880-895
pubmed: 33623657
Annu Rev Biophys Biomol Struct. 2007;36:451-77
pubmed: 17477841
World J Gastroenterol. 2017 Feb 28;23(8):1450-1457
pubmed: 28293092
PLoS One. 2012;7(11):e48670
pubmed: 23144924
Cancer Res. 2017 May 1;77(9):2328-2338
pubmed: 28202517
Methods Enzymol. 2010;484:677-95
pubmed: 21036256
Mol Cell Biol. 2004 Nov;24(22):9802-12
pubmed: 15509784
Structure. 2016 Feb 2;24(2):252-60
pubmed: 26774128
Science. 1998 Nov 20;282(5393):1484-7
pubmed: 9822378
Biochimie. 2008 Jan;90(1):83-92
pubmed: 17825467
Cell Rep. 2015 Oct 20;13(3):524-532
pubmed: 26456820
Cell Rep. 2017 Jul 18;20(3):737-749
pubmed: 28723574
EMBO Rep. 2012 Aug;13(8):724-32
pubmed: 22699936
Br J Cancer. 2016 Mar 1;114(5):545-53
pubmed: 26867158
Eur J Cell Biol. 2014 May-Jun;93(5-6):184-93
pubmed: 24629839
Cytoskeleton (Hoboken). 2015 Jul;72(7):362-71
pubmed: 26235381
Biochem J. 2005 Oct 15;391(Pt 2):177-84
pubmed: 16076287
Commun Biol. 2020 Mar 13;3(1):123
pubmed: 32170109
Front Cell Dev Biol. 2021 Feb 01;9:634708
pubmed: 33598464
Structure. 2016 Oct 4;24(10):1679-1692
pubmed: 27594684
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1500-5
pubmed: 22307604
PLoS One. 2015 Apr 24;10(4):e0124958
pubmed: 25909630
Nature. 2013 Nov 14;503(7475):281-4
pubmed: 24132237
Nat Rev Drug Discov. 2012 Dec;11(12):923-36
pubmed: 23197039

Auteurs

Gleb Simanov (G)

CNRS UMR7654, Institut Polytechnique de Paris, 91120 Palaiseau, France.

Irene Dang (I)

CNRS UMR7654, Institut Polytechnique de Paris, 91120 Palaiseau, France.

Artem I Fokin (AI)

CNRS UMR7654, Institut Polytechnique de Paris, 91120 Palaiseau, France.

Ksenia Oguievetskaia (K)

CNRS UMR7654, Institut Polytechnique de Paris, 91120 Palaiseau, France.

Valérie Campanacci (V)

Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France.

Jacqueline Cherfils (J)

Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France.

Alexis M Gautreau (AM)

CNRS UMR7654, Institut Polytechnique de Paris, 91120 Palaiseau, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH